CD38 and viral infectious disease: These included CD38 monoclonal antibodies and inhibitors which would modulate levels of NAD+ or vitamin B3 precursor administration (e.g., nicotinamide riboside, nicotinamide mononucleotide, nicotinamide), which would restore levels of NAD+ and the usual viral infection immune response [9].